Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Skin Neoplasms × Bleomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 45 Lymphoma 39 HIV Infections 11 Acquired Immunodeficiency Syndrome 11 Lymphoma, Large B-Cell, Diffuse 9 Testicular Neoplasms 8 Teratoma 8 Lymphoma, Non-Hodgkin 8 Sarcoma, Kaposi 7 Neoplasms 5 Lymphoma, Large-Cell, Immunoblastic 5 Lymphoma, Follicular 5 Head and Neck Neoplasms 5 Endodermal Sinus Tumor 5 Testicular Germ Cell Tumor 4 Recurrence 4 Ovarian Germ Cell Cancer 4 Neoplasm Metastasis 4 Carcinoma, Embryonal 4 Vulvar Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Seminoma 3 Ovarian Neoplasms 3 Neoplasms, Germ Cell and Embryonal 3 Carcinoma, Squamous Cell 3 Teratoma, Testicular 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Dendritic Cell Sarcoma, Interdigitating 2 Central Nervous System Neoplasms 2 Cardiotoxicity 2

Interventions

pembrolizumab 20 Nivolumab 20 aldesleukin 19 Cyclophosphamide 18 Ipilimumab 16 fludarabine 14 Interleukin-2 14 fludarabine phosphate 12 cemiplimab 11 Radiotherapy 7 Biopsy 7 dabrafenib 6 Surveys and Questionnaires 6 Fluorouracil 6 Dacarbazine 6 trametinib 5 Vemurafenib 5 Radiation 5 Blood Specimen Collection 5 Aminolevulinic Acid 5 binimetinib 4 Temozolomide 4 Surgical Procedures, Operative 4 Sirolimus 4 Educational Status 4 sonidegib 3 montanide ISA 51 3 encorafenib 3 avelumab 3 Sodium Chloride 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06647342 2025-01-23

BLESS

Zealand University Hospital

Phase 4 Recruiting

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡